ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Activated Coagulation Factor VII Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-24A11072
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Activated Coagulation Factor VII Market Research Report 2022
BUY CHAPTERS

Global Recombinant Activated Coagulation Factor VII Market Research Report 2025

Code: QYRE-Auto-24A11072
Report
January 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
AryoGen Pharmed
LFB SA HEMA Biologics

Recombinant Activated Coagulation Factor VII Market Size

The global market for Recombinant Activated Coagulation Factor VII was valued at US$ 1271 million in the year 2024 and is projected to reach a revised size of US$ 1633 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Recombinant Activated Coagulation Factor VII Market

Recombinant Activated Coagulation Factor VII Market

Coagulation Factor VIIa, recombinant is a coagulation factor indicated for: Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Activated Coagulation Factor VII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Activated Coagulation Factor VII.
The Recombinant Activated Coagulation Factor VII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Activated Coagulation Factor VII market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Activated Coagulation Factor VII manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Activated Coagulation Factor VII Market Report

Report Metric Details
Report Name Recombinant Activated Coagulation Factor VII Market
Accounted market size in year US$ 1271 million
Forecasted market size in 2031 US$ 1633 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Activated Coagulation Factor VII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Activated Coagulation Factor VII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant Activated Coagulation Factor VII Market growing?

Ans: The Recombinant Activated Coagulation Factor VII Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Recombinant Activated Coagulation Factor VII Market size in 2031?

Ans: The Recombinant Activated Coagulation Factor VII Market size in 2031 will be US$ 1633 million.

Who are the main players in the Recombinant Activated Coagulation Factor VII Market report?

Ans: The main players in the Recombinant Activated Coagulation Factor VII Market are Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed

What are the Application segmentation covered in the Recombinant Activated Coagulation Factor VII Market report?

Ans: The Applications covered in the Recombinant Activated Coagulation Factor VII Market report are Hemophilia A, Hemophilia B, Other

What are the Type segmentation covered in the Recombinant Activated Coagulation Factor VII Market report?

Ans: The Types covered in the Recombinant Activated Coagulation Factor VII Market report are Vial, Prefilled Syringe

Recommended Reports

Hemophilia & Coagulation

Recombinant Factor & Proteins

Blood & Coagulation Devices

1 Recombinant Activated Coagulation Factor VII Market Overview
1.1 Product Definition
1.2 Recombinant Activated Coagulation Factor VII by Type
1.2.1 Global Recombinant Activated Coagulation Factor VII Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vial
1.2.3 Prefilled Syringe
1.3 Recombinant Activated Coagulation Factor VII by Application
1.3.1 Global Recombinant Activated Coagulation Factor VII Market Value by Application (2024 VS 2031)
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Other
1.4 Global Recombinant Activated Coagulation Factor VII Market Size Estimates and Forecasts
1.4.1 Global Recombinant Activated Coagulation Factor VII Revenue 2020-2031
1.4.2 Global Recombinant Activated Coagulation Factor VII Sales 2020-2031
1.4.3 Global Recombinant Activated Coagulation Factor VII Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Activated Coagulation Factor VII Market Competition by Manufacturers
2.1 Global Recombinant Activated Coagulation Factor VII Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Activated Coagulation Factor VII Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Activated Coagulation Factor VII, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Activated Coagulation Factor VII, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Activated Coagulation Factor VII, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Activated Coagulation Factor VII, Date of Enter into This Industry
2.8 Global Recombinant Activated Coagulation Factor VII Market Competitive Situation and Trends
2.8.1 Global Recombinant Activated Coagulation Factor VII Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Activated Coagulation Factor VII Players Market Share by Revenue
2.8.3 Global Recombinant Activated Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Activated Coagulation Factor VII Market Scenario by Region
3.1 Global Recombinant Activated Coagulation Factor VII Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Activated Coagulation Factor VII Sales by Region: 2020-2031
3.2.1 Global Recombinant Activated Coagulation Factor VII Sales by Region: 2020-2025
3.2.2 Global Recombinant Activated Coagulation Factor VII Sales by Region: 2026-2031
3.3 Global Recombinant Activated Coagulation Factor VII Revenue by Region: 2020-2031
3.3.1 Global Recombinant Activated Coagulation Factor VII Revenue by Region: 2020-2025
3.3.2 Global Recombinant Activated Coagulation Factor VII Revenue by Region: 2026-2031
3.4 North America Recombinant Activated Coagulation Factor VII Market Facts & Figures by Country
3.4.1 North America Recombinant Activated Coagulation Factor VII Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Activated Coagulation Factor VII Sales by Country (2020-2031)
3.4.3 North America Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Activated Coagulation Factor VII Market Facts & Figures by Country
3.5.1 Europe Recombinant Activated Coagulation Factor VII Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Activated Coagulation Factor VII Sales by Country (2020-2031)
3.5.3 Europe Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Activated Coagulation Factor VII Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Activated Coagulation Factor VII Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Activated Coagulation Factor VII Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Activated Coagulation Factor VII Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Activated Coagulation Factor VII Market Facts & Figures by Country
3.7.1 Latin America Recombinant Activated Coagulation Factor VII Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Activated Coagulation Factor VII Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Activated Coagulation Factor VII Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Activated Coagulation Factor VII Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Activated Coagulation Factor VII Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Activated Coagulation Factor VII Sales by Type (2020-2031)
4.1.1 Global Recombinant Activated Coagulation Factor VII Sales by Type (2020-2025)
4.1.2 Global Recombinant Activated Coagulation Factor VII Sales by Type (2026-2031)
4.1.3 Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Activated Coagulation Factor VII Revenue by Type (2020-2031)
4.2.1 Global Recombinant Activated Coagulation Factor VII Revenue by Type (2020-2025)
4.2.2 Global Recombinant Activated Coagulation Factor VII Revenue by Type (2026-2031)
4.2.3 Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Activated Coagulation Factor VII Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Activated Coagulation Factor VII Sales by Application (2020-2031)
5.1.1 Global Recombinant Activated Coagulation Factor VII Sales by Application (2020-2025)
5.1.2 Global Recombinant Activated Coagulation Factor VII Sales by Application (2026-2031)
5.1.3 Global Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Activated Coagulation Factor VII Revenue by Application (2020-2031)
5.2.1 Global Recombinant Activated Coagulation Factor VII Revenue by Application (2020-2025)
5.2.2 Global Recombinant Activated Coagulation Factor VII Revenue by Application (2026-2031)
5.2.3 Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Activated Coagulation Factor VII Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Recombinant Activated Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Recombinant Activated Coagulation Factor VII Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 LFB SA HEMA Biologics
6.2.1 LFB SA HEMA Biologics Company Information
6.2.2 LFB SA HEMA Biologics Description and Business Overview
6.2.3 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
6.2.4 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Portfolio
6.2.5 LFB SA HEMA Biologics Recent Developments/Updates
6.3 AryoGen Pharmed
6.3.1 AryoGen Pharmed Company Information
6.3.2 AryoGen Pharmed Description and Business Overview
6.3.3 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Portfolio
6.3.5 AryoGen Pharmed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Activated Coagulation Factor VII Industry Chain Analysis
7.2 Recombinant Activated Coagulation Factor VII Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Activated Coagulation Factor VII Production Mode & Process Analysis
7.4 Recombinant Activated Coagulation Factor VII Sales and Marketing
7.4.1 Recombinant Activated Coagulation Factor VII Sales Channels
7.4.2 Recombinant Activated Coagulation Factor VII Distributors
7.5 Recombinant Activated Coagulation Factor VII Customer Analysis
8 Recombinant Activated Coagulation Factor VII Market Dynamics
8.1 Recombinant Activated Coagulation Factor VII Industry Trends
8.2 Recombinant Activated Coagulation Factor VII Market Drivers
8.3 Recombinant Activated Coagulation Factor VII Market Challenges
8.4 Recombinant Activated Coagulation Factor VII Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
AryoGen Pharmed
LFB SA HEMA Biologics
List of Tables
 Table 1. Global Recombinant Activated Coagulation Factor VII Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Activated Coagulation Factor VII Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Activated Coagulation Factor VII Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Activated Coagulation Factor VII Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Activated Coagulation Factor VII Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Activated Coagulation Factor VII Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Activated Coagulation Factor VII Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Activated Coagulation Factor VII, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Activated Coagulation Factor VII, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Activated Coagulation Factor VII, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Activated Coagulation Factor VII, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Activated Coagulation Factor VII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Activated Coagulation Factor VII as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Activated Coagulation Factor VII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Activated Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Activated Coagulation Factor VII Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Activated Coagulation Factor VII Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Activated Coagulation Factor VII Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Activated Coagulation Factor VII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Activated Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Activated Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Activated Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Activated Coagulation Factor VII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Activated Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Activated Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Activated Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Activated Coagulation Factor VII Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Activated Coagulation Factor VII Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Activated Coagulation Factor VII Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Activated Coagulation Factor VII Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Activated Coagulation Factor VII Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Activated Coagulation Factor VII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Activated Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Activated Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Activated Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Activated Coagulation Factor VII Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Activated Coagulation Factor VII Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Activated Coagulation Factor VII Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Activated Coagulation Factor VII Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Activated Coagulation Factor VII Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Activated Coagulation Factor VII Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Activated Coagulation Factor VII Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Activated Coagulation Factor VII Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Activated Coagulation Factor VII Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Activated Coagulation Factor VII Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Activated Coagulation Factor VII Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Activated Coagulation Factor VII Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Activated Coagulation Factor VII Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Activated Coagulation Factor VII Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Activated Coagulation Factor VII Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Activated Coagulation Factor VII Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Activated Coagulation Factor VII Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Activated Coagulation Factor VII Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Activated Coagulation Factor VII Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Recombinant Activated Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Recombinant Activated Coagulation Factor VII Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. LFB SA HEMA Biologics Company Information
 Table 76. LFB SA HEMA Biologics Description and Business Overview
 Table 77. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product
 Table 79. LFB SA HEMA Biologics Recent Developments/Updates
 Table 80. AryoGen Pharmed Company Information
 Table 81. AryoGen Pharmed Description and Business Overview
 Table 82. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product
 Table 84. AryoGen Pharmed Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Recombinant Activated Coagulation Factor VII Distributors List
 Table 88. Recombinant Activated Coagulation Factor VII Customers List
 Table 89. Recombinant Activated Coagulation Factor VII Market Trends
 Table 90. Recombinant Activated Coagulation Factor VII Market Drivers
 Table 91. Recombinant Activated Coagulation Factor VII Market Challenges
 Table 92. Recombinant Activated Coagulation Factor VII Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Activated Coagulation Factor VII
 Figure 2. Global Recombinant Activated Coagulation Factor VII Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Activated Coagulation Factor VII Market Share by Type: 2024 & 2031
 Figure 4. Vial Product Picture
 Figure 5. Prefilled Syringe Product Picture
 Figure 6. Global Recombinant Activated Coagulation Factor VII Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Activated Coagulation Factor VII Market Share by Application: 2024 & 2031
 Figure 8. Hemophilia A
 Figure 9. Hemophilia B
 Figure 10. Other
 Figure 11. Global Recombinant Activated Coagulation Factor VII Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Activated Coagulation Factor VII Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Activated Coagulation Factor VII Sales (2020-2031) & (K Units)
 Figure 14. Global Recombinant Activated Coagulation Factor VII Average Price (US$/Unit) & (2020-2031)
 Figure 15. Recombinant Activated Coagulation Factor VII Report Years Considered
 Figure 16. Recombinant Activated Coagulation Factor VII Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Activated Coagulation Factor VII Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Activated Coagulation Factor VII Players: Market Share by Revenue in Recombinant Activated Coagulation Factor VII in 2024
 Figure 19. Recombinant Activated Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Activated Coagulation Factor VII Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2020-2031)
 Figure 23. United States Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Activated Coagulation Factor VII Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Activated Coagulation Factor VII Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Recombinant Activated Coagulation Factor VII Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Recombinant Activated Coagulation Factor VII Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Recombinant Activated Coagulation Factor VII Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Recombinant Activated Coagulation Factor VII by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant Activated Coagulation Factor VII by Type (2020-2031)
 Figure 55. Global Recombinant Activated Coagulation Factor VII Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Recombinant Activated Coagulation Factor VII by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Recombinant Activated Coagulation Factor VII by Application (2020-2031)
 Figure 58. Global Recombinant Activated Coagulation Factor VII Price (US$/Unit) by Application (2020-2031)
 Figure 59. Recombinant Activated Coagulation Factor VII Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Human Coagulation Factor VII Market Insights Forecast to 2030
Coagulation Factor VIIa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factors Market Insights Forecast to 2030
Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Global Eptacog Alfa rFVIIa Market Research Report 2025
Eptacog Alfa Recombinant Human Coagulation Factor VIIa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma derived Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Coagulation Factor IX Market Research Report 2025
Global Coagulation Factor Concentrate Market Research Report 2025
Global Recombinant Human Coagulation VIIa Market Research Report 2025
Global Recombinant Human Thrombin Protein Market Research Report 2024
Global Recombinant Plasma Proteins Market Insights Forecast to 2030
Global Recombinant Antihemophilic Globulin Market Research Report 2024
Hemophilia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions